Biotech

All Articles

ArsenalBio increases $325M, turns off of previous lead possession

.Collection Biosciences is actually proceeding up. The cell treatment firm has added on $325 thousan...

Lilly- backed weight-loss biotech reports IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana make use of medication fails stage 2b, steering Indivior to review $100M alternative

.Aelis Farma's hopes of securing a simple, positive choice on a $100 million choice payment have act...

ProKidney standstills phase 3 trial not needed to have for cell treatment confirmation

.ProKidney has stopped one of a set of stage 3 tests for its own cell treatment for renal condition ...

Vaxcyte climbs on 'stunning' 31-valent PCV gain versus Pfizer

.Vaxcyte revealed what experts named "spectacular" stage 1/2 information for its 31-valent pneumococ...

Recursion's brain disease trial reveals insufficient evidence of efficiency

.Recursion has actually stumbled by means of an early exam of its own tech-enabled approach to medic...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Call it an instance of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning scie...

Praxis epilepsy drug decreases seizures in phase 2 hearing

.Praxis Accuracy Medicines has actually scored one more midphase win in epilepsy this year, with its...

Three officers surrender as Dyne messages blended records for DMD applicant

.After running away a professional hold numerous years back, Dyne Rehab has actually shown new stage...

Arrowhead fires off stage 3 information in uncommon metabolic ailment ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its give ahead of a prospective showdown along wit...